Nicorette (nicotine polacrilex)

SmithKline Beecham

Approval Status
Approved February 1996

Treatment for
smoking cessation

Psychiatry / Psychiatric

Nicorette has been approved as an over-the-counter (OTC) aid in smoking cessation. The OTC nicotine gum product will be available in the same dosage strengths as the prescription product.

Nicorette relieves withdrawal symptoms by providing a temporary alternative source of nicotine, thereby easing the transition for an individual committed to smoking cessation. The nicotine in Nicorette reaches the bloodstream more gradually and at lower doses than delivered by cigarettes. While Nicorette controls withdrawal symptoms, thus addressing the physical addiction of smoking, the individual works to control the social and psychological aspects of the smoking habit.

The OTC version of Nicorette will be available in prescription strengths of 2 mg and 4 mg.

Nicorette (nicotine polacrilex) Drug Information

The Nicorette (nicotine polacrilex) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top